A Study of Olaratumab in Japanese Participants With Advanced Cancer
Clinical trial NCT02377752 · COMPLETED
Trial details
- NCT number
- NCT02377752
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-23
- Primary completion
- 2018-08-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.